Search

everythinglearnresearchcommunity

for

Search:↓

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Minoxidil promotes hair growth in women with early-stage alopecia.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Doctors need to be better prepared to assess and treat obesity in patients.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

SHBG may be a useful early indicator and treatment target for PCOS.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.